Asked by: Baroness Thomas of Winchester (Liberal Democrat - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what assessment they have made of the delays faced by those ordering essential disability equipment from overseas.
Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)
No such assessment has been made. At this time the Department is not centrally managing any shortages related to delayed overseas orders of disability equipment. We would encourage any specific detail of supply issues to be shared with the Department.
The Department's National Supply Disruption Response team works with system partners to help mitigate supply issues, including through the coordination of mutual aid, identifying alternative products or clinical practices, regulatory easements, and/or use of the Express Freight Service which can provide bespoke global logistics services in the event of critical supply disruption.
Asked by: Baroness Thomas of Winchester (Liberal Democrat - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government whether they will take steps to enable specialist medical equipment to reach disabled people in the community following the liquidation of NRS Healthcare.
Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)
Community equipment, such as wheelchairs, hoists, and other specialist medical equipment, forms an important part of many people’s health and care support package. Such equipment can be critical in supporting better care outcomes, can enable people to remain in or return to their homes as the primary setting for care, and can avoid unnecessary stays in hospital or care homes.
Local authorities have statutory duties under the Care Act 2014 and the Children and Families Act 2014 to arrange for the provision of disability aids and community equipment to meet the assessed needs of individuals in their area. While some local authorities provide these services themselves, many have contracts with external suppliers, such as NRS Healthcare. The Department does not have a statutory role in the provision of community equipment.
However, as part of NRS Healthcare’s liquidation process, the Government made available short-term funding to the Official Receiver to cover the essential operating costs of NRS Healthcare and its affiliated companies. This funding ensured that trading was able to continue for a limited time, minimising disruption by providing crucial time for local authorities to put alternative supply in place. The Department continues to monitor the situation in affected local authorities through Partners in Care and Health, a Department funded programme run in partnership with the Local Government Association and the Association of Directors of Adult Social Services.
Asked by: Baroness Thomas of Winchester (Liberal Democrat - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what consideration they will give to recent research which has shown that a blood test can detect ovarian cancer.
Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)
The Department is committed to improving cancer care for patients across England, including those with ovarian cancer.
As the chances of survival are higher if a cancer is diagnosed at an early stage, early diagnosis is a key priority for the Government. Several tests are currently used to detect ovarian cancer including ultrasound scans, biopsies and blood tests.
The forthcoming National Cancer Plan, which will complement the 10-Year Health Plan, will include further details on how we will improve outcomes for all cancer patients including those with ovarian cancer. In addition to speeding up diagnosis and treatment it will aim to ensure that patients have access to the latest treatments and technology and to clinical and will ultimately bring this country’s cancer survival rates back up to the standards of the best in the world. The Department ran a Call for Evidence to inform the development of the national cancer plan, including a question on priorities for cancer research. Over 11,000 responses were received, and these responses have been analysed to prioritise recommendations in the Plan.
The Government recognises that investment is needed across the research pathway, from cellular biology and drug discovery through to translation and application. At the start of that pathway, the Government funds the Medical Research Council through UK Research and Innovation, which in turn works closely with the National Institute for Health and Care Research to identify emerging, viable prospects for translational research.
Alongside, the Government is supporting the Private Members Bill on rare cancers tabled by the Hon. Member for Edinburgh South West (Scott Arthur MP). In developing the bill, a wide range of research and evidence has been considered. The bill will make it easier for clinical trials and research into rare cancers, such as ovarian cancer, to take place in England by ensuring the patient population can be easily contacted by researchers.
More generally, across the field of cancer research, the Department works with relevant bodies to consider the impact of emerging research and associated outcomes, where possible and appropriate. As the question does not name the specific research programme, it is not possible to provide any further detail about the Department’s or associated bodies’ consideration to the research to which the question refers.
Asked by: Baroness Thomas of Winchester (Liberal Democrat - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what steps they will take to ensure that integrated care boards are providing sufficient suitable wheelchairs in all parts of the country to enable wheelchair users, particularly children, to access one without delay.
Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)
Integrated care boards (ICBs) are responsible for the provision and commissioning of local wheelchair services, including children’s wheelchair services, and the development of their local wheelchair service eligibility criteria, based on the needs of their local population. NHS England supports ICBs to commission effective, efficient, and personalised wheelchair services.
NHS England is taking a number of steps to reduce regional variation in the quality and provision of National Health Service wheelchairs, and to support ICBs to reduce delays in people receiving timely intervention and wheelchair equipment. These include: